 |
|
Systematic Overview of Warfarin and Its Drug and Food Interactions
Anne M. Holbrook, MD, PharmD, MSc, FRCPC;
Jennifer A. Pereira, MSc;
Renee Labiris, PhD;
Heather McDonald, MSc;
James D. Douketis, MD, FRCPC;
Mark Crowther, MD, MSc, FRCPC;
Philip S. Wells, MD, FRCPC
Arch Intern Med. 2005;165:1095-1106.
Background Warfarin is a highly efficacious oral anticoagulant, but its use is limited by a well-founded fear of bleeding. Drug and food interactions are frequently cited as causes of adverse events with warfarin. We provide an updated systematic overview of the quality, clinical effect, and importance of these reported interactions.
Data Sources MEDLINE, TOXLINE, IPA, and EMBASE databases from October 1993 to March 2004. Database searches combined the keyword warfarin with drug interactions, herbal medicines, Chinese herbal drugs, and food-drug interactions.
Study Selection Eligible articles contained original reports of warfarin drug or food interactions in human subjects. Non-English articles were included if sufficient information could be abstracted.
Data Extraction Reports were rated independently by 2 investigators for interaction direction, clinical severity, and quality of evidence. Quality of evidence was based on previously validated causation criteria and study design.
Data Synthesis Of 642 citations retrieved, 181 eligible articles contained original reports on 120 drugs or foods. Inter-rater agreement was excellent, with weighted  values of 0.84 to 1.00. Of all reports, 72% described a potentiation of warfarin’s effect and 84% were of poor quality, 86% of which were single case reports. The 31 incidents of clinically significant bleeding were all single case reports. Newly reported interactions included celecoxib, rofecoxib, and herbal substances, such as green tea and danshen.
Conclusions The number of drugs reported to interact with warfarin continues to expand. While most reports are of poor quality and present potentially misleading conclusions, the consistency of reports of interactions with azole antibiotics, macrolides, quinolones, nonsteroidal anti-inflammatory drugs, including selective cyclooxygenase-2 inhibitors, selective serotonin reuptake inhibitors, omeprazole, lipid-lowering agents, amiodarone, and fluorouracil, suggests that coadministration with warfarin should be avoided or closely monitored. More systematic study of warfarin drug interactions in patients is urgently needed.
Author Affiliations: Centre for Evaluation of Medicines, St Joseph’s Healthcare, Hamilton, Ontario (Drs Holbrook and Labiris and Ms Pereira); Department of Medicine, McMaster University, Hamilton (Drs Holbrook, Labiris, Douketis, and Crowther); Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario (Dr Holbrook and Ms Pereira); Axon Clinical Research, Toronto (Ms McDonald) and Ottawa Civic Hospital Research Centre, Ottawa, Ontario (Dr Wells).
RELATED LETTERS
Comments on the Important Drug Interaction of Warfarin and Sulfamethoxazole
John Erwin Campbell and William H. Carter
Arch Intern Med. 2005;165(21):2540.
EXTRACT
| FULL TEXT
Comments on the Important Drug Interaction of Warfarin and Sulfamethoxazole—Reply
Anne Holbrook and Jennifer Pereira
Arch Intern Med. 2005;165(21):2540.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Occurrence and Characteristics of Stroke Events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) Study
David G. Sherman, Soo G. Kim, Bradley S. Boop, Scott D. Corley, John P. DiMarco, Robert G. Hart, L. Julian Haywood, Keith Hoyte, Elizabeth S. Kaufman, Michael H. Kim, Elaine Nasco, Albert L. Waldo, and for the National Heart, Lung, and Blood Institute AFFIRM Investigators
Arch Intern Med. 2005;165(10):1185-1191.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Interaction between statins and clopidogrel: is there anything clinically relevant?
Bhindi et al.
QJM 2008;0:hcn089v1-hcn089.
ABSTRACT
| FULL TEXT
Azathioprine-Induced Warfarin Resistance
Vazquez et al.
The Annals of Pharmacotherapy 2008;42:1118-1123.
ABSTRACT
| FULL TEXT
Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Ansell et al.
Chest 2008;133:160S-198S.
ABSTRACT
| FULL TEXT
Overanticoagulation with Coumarin and Cutaneous Azole Therapy
Alexandra et al.
ANN INTERN MED 2008;148:633-635.
FULL TEXT
Primary Prevention of Venous Thromboembolism in Long-Term Care: Identifying and Managing the Risk
Haas and Spyropoulos
CLIN APPL THROMB HEMOST 2008;14:149-158.
ABSTRACT
Increased Bleeding Risk With Concurrent Use of Selective Serotonin Reuptake Inhibitors and Coumarins
Schalekamp et al.
Arch Intern Med 2008;168:180-185.
ABSTRACT
| FULL TEXT
Glucuronidation of Monohydroxylated Warfarin Metabolites by Human Liver Microsomes and Human Recombinant UDP-Glucuronosyltransferases
Zielinska et al.
J. Pharmacol. Exp. Ther. 2008;324:139-148.
ABSTRACT
| FULL TEXT
Optimal Initial Dose Adjustment of Warfarin in Orthopedic Patients
Lenzini et al.
The Annals of Pharmacotherapy 2007;41:1798-1804.
ABSTRACT
| FULL TEXT
Interaction between lopinavir/ritonavir and warfarin
Hughes et al.
CMAJ 2007;177:357-359.
ABSTRACT
| FULL TEXT
Drug interactions with warfarin: what clinicians need to know
Juurlink
CMAJ 2007;177:369-371.
FULL TEXT
Potential drug-drug interactions within Veterans Affairs medical centers
Mahmood et al.
Am J Health Syst Pharm 2007;64:1500-1505.
ABSTRACT
| FULL TEXT
Best practice in primary care pathology: review 8
Smellie et al.
J. Clin. Pathol. 2007;60:740-748.
ABSTRACT
| FULL TEXT
Interaction potential between cranberry juice and warfarin
Pham and Pham
Am J Health Syst Pharm 2007;64:490-494.
ABSTRACT
| FULL TEXT
Significant Pharmacokinetic and Pharmacodynamic Interaction of Warfarin With the NO-Independent sGC Activator HMR1766
Oberwittler et al.
J Clin Pharmacol 2007;47:70-77.
ABSTRACT
| FULL TEXT
Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review.
Johnson et al.
Eur Respir J 2006;28:999-1004.
ABSTRACT
| FULL TEXT
Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin: Assessment of Incidence, Case-Fatality Rate, Time Course and Sites of Bleeding, and Risk Factors for Bleeding.
Douketis et al.
Arch Intern Med 2006;166:853-859.
ABSTRACT
| FULL TEXT
Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors
Gerber et al.
JCO 2006;24:1310-1318.
ABSTRACT
| FULL TEXT
Evidently ...
LEHMAN
Evid. Based Med. 2005;10:167-167.
FULL TEXT
Other articles noted
Evid. Based Med. 2005;10:191-192.
FULL TEXT
Comments on the Important Drug Interaction of Warfarin and Sulfamethoxazole
Campbell and Carter
Arch Intern Med 2005;165:2540-2540.
FULL TEXT
|
